Skip to main content

Table 5 Comparison between HEP and LF in patients with known or suspected cardiac sarcoidosis

From: Long fasting is effective in inhibiting physiological myocardial 18F-FDG uptake and for evaluating active lesions of cardiac sarcoidosis

 

HEP

LF

p value

 

N

Average ± SD

N

Average ± SD

Age (years)

96

57.19 ± 13.88

69

56.94 ± 13.16

0.91

Gender

96

M/F = 37:59

69

M/F = 17:52

0.06

FBG

96

99.68 ± 14.12

69

92.80 ± 13.35

0.002**

FFA

96

0.81 ± 0.39

69

1.02 ± 0.41

0.001**

BMI

96

22.37 ± 3.39

69

21.83 ± 3.08

0.28

Phy U

96

2.46 ± 1.33

69

1.48 ± 0.99

<0.0001***

Steroid use

96

19

69

14

0.98

  1. HEP, heparin loading plus 12-h fasting; LF, 16-h or more fasting; FBG, fasting blood glucose (mg/dL); FFA, plasma free fatty acids (mEq/L); BMI, body mass index; Phy U, physiological uptake grades 1 to 4; ** p < 0.01; *** p < 0.001.